Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Atherosclerosis of the extracranial internal carotid artery (ICA) causes 10–20% of ischaemic strokes.1 As luminal stenosis of the ICA grows, the risk of ischaemic stroke increases,2 and removal of the ...

A new study could lead to more widespread use of imaging technique to improve survival and prevent complications.

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

The aging population, sedentary lifestyles, and the rising prevalence of diabetes and smoking contribute to the growing incidence of Peripheral Artery Disease (PAD), a major subset of PVD. This surge ...

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...

The British Heart Foundation estimates around one in five people over the age of 60 have some degree of peripheral artery disease. The Intermountain Health study focused on the American population ...

Several studies have described possible reasons for the decrease in B lymphocytes in peripheral blood of PD patients, such as clinical severity (H&Y), disease progresses, disease duration, and ...

Medical experts warn that persistently cold hands might be a sign of a silent but severe heart condition—Peripheral Artery Disease (PAD)—linked to high cholesterol levels. Peripheral Artery ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with type 2 diabetes and a vascular disorder known as peripheral artery ...